{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:06:38Z","timestamp":1790291198238,"version":"4.1.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Accuray, Inc"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.ijrobp.2019.03.010","type":"journal-article","created":{"date-parts":[[2019,3,14]],"date-time":"2019-03-14T12:47:40Z","timestamp":1552567660000},"page":"110-118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Phase 1 Fractional Dose-Escalation Study of Equipotent Stereotactic Radiation Therapy Regimens for Early-Stage Glottic Larynx Cancer"],"prefix":"10.1016","volume":"105","author":[{"given":"David J.","family":"Sher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D.","family":"Timmerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucien","family":"Nedzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuxiong","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nhat-Long","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baran D.","family":"Sumer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2019.03.010_bib1","first-page":"7","article-title":"Cancer statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ijrobp.2019.03.010_bib3","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ijrobp.2009.08.066","article-title":"T1N0 to T2N0 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapy","volume":"78","author":"Chera","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2019.03.010_bib4","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1002\/cncr.20181","article-title":"Management of T1-T2 glottic carcinomas","volume":"100","author":"Mendenhall","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2019.03.010_bib5","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ijrobp.2014.06.032","article-title":"Voice quality after treatment of early vocal cord cancer: A randomized trial comparing laser surgery with radiation therapy","volume":"90","author":"Aaltonen","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2019.03.010_bib6","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.ijrobp.2009.07.1687","article-title":"Carotid-sparing intensity-modulated radiotherapy for early-stage squamous cell carcinoma of the true vocal cord","volume":"77","author":"Chera","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2019.03.010_bib7","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.oraloncology.2015.02.003","article-title":"Carotid sparing intensity-modulated radiation therapy achieves comparable locoregional control to conventional radiotherapy in T1-2N0 laryngeal carcinoma","volume":"51","author":"Zumsteg","year":"2015","journal-title":"Oral Oncol"},{"key":"10.1016\/j.ijrobp.2019.03.010_bib8","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ijrobp.2015.06.016","article-title":"Single vocal cord irradiation: Image guided intensity modulated hypofractionated radiation therapy for T1a glottic cancer: Early clinical results","volume":"93","author":"Al-Mamgani","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2019.03.010_bib9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2016.11.005","article-title":"Stereotactic ablative body radiosurgery (SABR) or stereotactic body radiation therapy (SBRT)","volume":"109","author":"Folkert","year":"2017","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.ijrobp.2019.03.010_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172055","article-title":"SBRT for early-stage glottis larynx cancer- Initial clinical outcomes from a phase I clinical trial","volume":"12","author":"Schwartz","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ijrobp.2019.03.010_bib11","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.meddos.2018.02.006","article-title":"Cyberknife stereotactic radiosurgery and radiation therapy treatment planning system","volume":"43","author":"Ding","year":"2018","journal-title":"Med Dosim"},{"key":"10.1016\/j.ijrobp.2019.03.010_bib12","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.ijrobp.2007.10.059","article-title":"Universal survival curve and single fraction equivalent dose: Useful tools in understanding potency of ablative radiotherapy","volume":"70","author":"Park","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2019.03.010_bib13","doi-asserted-by":"crossref","first-page":"526","DOI":"10.2307\/3575730","article-title":"In\u00a0vitro radiosensitivity of six human cell lines. II. Relation to the RBE of 50-MeV neutrons","volume":"90","author":"Fertil","year":"1982","journal-title":"Radiat Res"},{"key":"10.1016\/j.ijrobp.2019.03.010_bib14","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1002\/lary.27001","article-title":"Minimal clinically important difference of Voice Handicap Index-10 in vocal fold paralysis","volume":"128","author":"Young","year":"2018","journal-title":"Laryngoscope"},{"key":"10.1016\/j.ijrobp.2019.03.010_bib15","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1002\/lary.27226","article-title":"Study design and early result of a phase I study of SABR for early-stage glottic cancer","volume":"128","author":"Yu","year":"2018","journal-title":"Laryngoscope"},{"key":"10.1016\/j.ijrobp.2019.03.010_bib16","first-page":"4155","article-title":"Exclusive radiotherapy for early-stage glottic cancer: A single-institution retrospective analysis with a focus on voice quality","volume":"35","author":"Potenza","year":"2015","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ijrobp.2019.03.010_bib17","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00405-013-2608-8","article-title":"Radiotherapy for T1a glottic cancer: The influence of smoking cessation and fractionation schedule of radiotherapy","volume":"271","author":"Al-Mamgani","year":"2014","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.ijrobp.2019.03.010_bib18","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.semradonc.2017.04.007","article-title":"Emphasis on repair, not just avoidance of injury, facilitates prudent stereotactic ablative radiotherapy","volume":"27","author":"Kim","year":"2017","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2019.03.010_bib19","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.ijrobp.2016.02.049","article-title":"Risk of severe toxicity according to site of recurrence in patients treated with stereotactic body radiation therapy for recurrent head and neck cancer","volume":"95","author":"Ling","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2019.03.010_bib20","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/0360-3016(86)90071-4","article-title":"Distribution of radiation sensitivities for human tumor cells of specific histological types: Comparison of in\u00a0vitro to in\u00a0vivo data","volume":"12","author":"Malaise","year":"1986","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2019.03.010_bib21","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1200\/JCO.2001.19.20.4029","article-title":"T1-T2N0 squamous cell carcinoma of the glottic larynx treated with radiation therapy","volume":"19","author":"Mendenhall","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2019.03.010_bib22","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1002\/hed.25142","article-title":"Cost-effectiveness analysis of salvage therapies in locoregional previously irradiated head and neck cancer","volume":"40","author":"Kim","year":"2018","journal-title":"Head Neck"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301619303232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301619303232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T09:44:30Z","timestamp":1759743870000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301619303232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0360301619303232"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2019.03.010","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phase 1 Fractional Dose-Escalation Study of Equipotent Stereotactic Radiation Therapy Regimens for Early-Stage Glottic Larynx Cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2019.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}